A multicenter study published online May 16 by The Lancet has shown that a combination of MRI and mammography offers the best means of detecting breast cancer in women with a high genetic risk for the disease.
A multicenter study published online May 16 by The Lancet has shown that a combination of MRI and mammography offers the best means of detecting breast cancer in women with a high genetic risk for the disease.
The investigators found MRI significantly more sensitive than mammography (77% versus 40%) in detecting breast cancers across the group of 649 women. Combining the results increased the sensitivity to 94%. MRI proved especially effective in BRCA1 mutation carriers, in whom it detected all tumors. Both techniques were needed to spot all cancers in women carrying BRCA2 mutations.
Commenting on the study, Dr. Ellen Warner, a medical oncologist at Toronto-Sunnybrook Regional Cancer Centre, said that mammography may one day be abandoned for high-risk women.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
Philips Launches Flash 5100 Point-of-Care Ultrasound System
June 17th 2025Offering a combination of intuitive touchscreen controls and enhanced image clarity, the portable Flash 5100 POC ultrasound platform reportedly facilitates confident and rapid assessment in emergency radiology and critical care settings.